Cheniere Energy Partners, L.P. (CQP)

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	9,894	8,639	9,601	17,143	9,381	6,126
Other Revenue	65	65	63	63	53	41
Revenue	9,959	8,704	9,664	17,206	9,434	6,167
Revenue Growth (YoY)	10.62%	-9.93%	-43.83%	82.38%	52.98%	-9.81%
Cost of Revenue	5,983	4,628	3,850	13,095	6,214	3,376
Gross Profit	3,976	4,076	5,814	4,111	3,220	2,791
Selling, General & Admin	102	100	99	97	94	110
Other Operating Expenses	10	16	7	-	12	5
Operating Expenses	796	796	778	731	663	666
Operating Income	3,180	3,280	5,036	3,380	2,557	2,125
Interest Expense	-774	-800	-823	-870	-831	-909
Interest & Investment Income	24	33	46	21	1	-
Other Non Operating Income (Expenses)	22	-	1	-	4	10
EBT Excluding Unusual Items	2,452	2,513	4,260	2,531	1,731	1,226
Other Unusual Items	-	-3	-6	-33	-101	-43
Pretax Income	2,452	2,510	4,254	2,498	1,630	1,183
Net Income	2,452	2,510	4,254	2,498	1,630	1,183
Preferred Dividends & Other Adjustments	457	450	892	915	180	117
Net Income to Common	1,995	2,060	3,362	1,583	1,450	1,066
Net Income Growth	-16.85%	-41.00%	70.30%	53.25%	37.79%	0.68%
Shares Outstanding (Basic)	484	484	484	484	484	484
Shares Outstanding (Diluted)	484	484	484	484	484	484
EPS (Basic)	4.12	4.26	6.95	3.27	3.00	2.20
EPS (Diluted)	4.12	4.26	6.95	3.27	3.00	2.20
EPS Growth	-12.71%	-38.73%	112.38%	9.17%	36.02%	-2.11%
Free Cash Flow	2,574	2,814	2,889	3,698	1,643	779
Free Cash Flow Per Share	5.32	5.81	5.97	7.64	3.40	1.61
Dividend Per Share	3.045	3.250	4.125	4.250	2.705	2.590
Dividend Growth	-22.12%	-21.21%	-2.94%	57.12%	4.44%	5.29%
Gross Margin	39.92%	46.83%	60.16%	23.89%	34.13%	45.26%
Operating Margin	31.93%	37.68%	52.11%	19.64%	27.10%	34.46%
Profit Margin	20.03%	23.67%	34.79%	9.20%	15.37%	17.29%
Free Cash Flow Margin	25.85%	32.33%	29.89%	21.49%	17.42%	12.63%
EBITDA	3,864	3,960	5,708	4,014	3,114	2,676
EBITDA Margin	38.80%	45.50%	59.06%	23.33%	33.01%	43.39%
D&A For EBITDA	684	680	672	634	557	551
EBIT	3,180	3,280	5,036	3,380	2,557	2,125
EBIT Margin	31.93%	37.68%	52.11%	19.64%	27.10%	34.46%
Revenue as Reported	9,959	8,704	9,664	17,206	9,434	6,167

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q